Osteogenesis imperfecta (OI) refers to a group of rare genetic bone disorders that results in the formation of fragile bones. In patients with OI, the matrix that makes up the bone has been found to ...
Leibniz Institute for Primate Research, the University Medical Center Göttingen, and the Max Planck Institute for ...
Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice Genetically engineered mouse models (GEMMs) of ...
The new Shank3 Exon 4-22 deletion model is engineered with loxP sites flanking exons 4–22 of the Shank3 gene. When crossed with Cre-driver lines, these exons can be excised to generate a full Shank3 ...
Researchers develop a genetically modified mouse model to uncover the links between dendrite defects in osteocytes and impaired bone remodeling CHINA, August 12, 2025 ...